SCHEMBL20219679

SCHEMBL20219679

CCCCNc1nc(CC)ncc1O[C@H](C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 5/20 0.40
▸ TLR7 Q9NYK1 4/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ SRC P12931 4/20 0.39
▸ ABL1 P00519 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ACP1 P24666 1/20 0.38
▸ ADORA1 P30542 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ UTS2R Q9UKP6 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23472189 0.87 TLR8 (0.41) TLR8TLR7CYP1A2CYP2D6SRC
SCHEMBL15469963 0.86 TLR8 (0.50) TLR8TLR7CYP1A2CYP2D6L3MBTL1
SCHEMBL15469961 0.86 TLR8 (0.50) TLR8TLR7CYP1A2CYP2D6L3MBTL1
SCHEMBL13195744 0.86 TLR8 (0.50) TLR8TLR7CYP1A2CYP2D6L3MBTL1
SCHEMBL15469957 0.84 TLR8 (0.47) TLR8TLR7CYP1A2CYP2D6L3MBTL1
SCHEMBL23472446 0.83 TLR8 (0.39) TLR8TLR7CYP1A2CYP2D6SRC
SCHEMBL20219506 0.81 SRC (0.44) TLR8TLR7CYP1A2CYP2D6SRC
SCHEMBL20219480 0.79 LMNA (0.45) TLR8CYP1A2CYP2D6SRCABL1
SCHEMBL23472515 0.79 APP (0.47) TLR8TLR7CYP1A2CYP2D6SRC
SCHEMBL23472169 0.74 TLR8 (0.41) TLR8TLR7CYP1A2CYP2D6SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback